TPPU | Soluble epoxide hydrolase inhibitor

TPPU chemical structure Focus Biomolecules

Available Options

Size:PriceQuantity 
5 mg$80.00
25 mg$275.00
Request Quote / Bulk / Custom Size
Product Inquiry

TPPU (1222780-33-7) is a potent and selective inhibitor of both murine and human soluble epoxide hydrolase, IC50=2.8 and 3.7 nM respectively.1 It alleviated blood brain barrier damage and attenuated neuronal injury in a mouse intracerebral hemorrhage model2 and displays neuroprotective effects in ischemic injury3. It reduces neuroinflammation in a mouse model of Alzheimer’s disease.4 It improves insulin resistance and reduced hypertension in mouse models.5 Cell permeable and active in vivo.

References/Citations:

  1. Rose et al. (2010), 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain; J. Med. Chem. 53 7067
  2. Tian et al. (2021), Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice; Neurochem. Int. 150 105197
  3. Yi et al. (2021), 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea Exerts Neuro-Protective Effects Against Ischemic Injury via Suppressing JNK/p38 MAPK-Mediated Mitochondrial Apoptosis Pathway; J. Stroke Cerebrovasc. Dis. 30 105957
  4. Ghosh et al. (2020), An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer’s disease; Sci. Transl. Med. 12 eabb1206
  5. Luo et al. (2021), Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney; J. Biol. Chem. 296 100667
1222780-33-7, Soluble epoxide hydrolase inhibitor, TPPU, TPPU supplier

Safety Data Sheet:

N/A

Product Data Sheet:

Download Product Data Sheet

Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee

TPPU (1222780-33-7) is a potent and selective inhibitor of both murine and human soluble epoxide hydrolase, IC50=2.8 and 3.7 nM respectively.1 It alleviated blood brain barrier damage and attenuated neuronal injury in a mouse intracerebral hemorrhage model2 and displays neuroprotective effects in ischemic injury3. It reduces neuroinflammation in a mouse model of Alzheimer’s disease.4 It improves insulin resistance and reduced hypertension in mouse models.5 Cell permeable and active in vivo.

References/Citations:

  1. Rose et al. (2010), 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain; J. Med. Chem. 53 7067
  2. Tian et al. (2021), Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice; Neurochem. Int. 150 105197
  3. Yi et al. (2021), 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea Exerts Neuro-Protective Effects Against Ischemic Injury via Suppressing JNK/p38 MAPK-Mediated Mitochondrial Apoptosis Pathway; J. Stroke Cerebrovasc. Dis. 30 105957
  4. Ghosh et al. (2020), An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer’s disease; Sci. Transl. Med. 12 eabb1206
  5. Luo et al. (2021), Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney; J. Biol. Chem. 296 100667